Synchronous bilateral breast cancer treated with a 3-week hypofractionated radiotherapy schedule: clinical and dosimetric outcomes

BACKGROUND AND PURPOSE: Synchronous bilateral breast cancer (SBBC) accounts for 1–3.5% of breast cancer patients. The aim of this study was to evaluate dosimetric issues, clinical outcomes, and acute toxicities for SBBC patients receiving synchronous bilateral hypofractionated radiotherapy (SBHRT) a...

Descripción completa

Detalles Bibliográficos
Autores principales: Gadea, J., Ortiz, I., Roncero, R., Alastuey, I., Mestre, F., Aymar, N., Maturana, J. E., Garcia, C., Mateu, L., Pardo, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8026808/
https://www.ncbi.nlm.nih.gov/pubmed/33830442
http://dx.doi.org/10.1007/s12094-021-02600-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8026808/
https://www.ncbi.nlm.nih.gov/pubmed/33830442
http://dx.doi.org/10.1007/s12094-021-02600-1

Ejemplares similares